LibraMed is a medical device that supports the treatment of overweight and obesity, also suitable for use in case of increased waist circumference. The tablets help control the postprandial glycemic peak while reducing fat absorption and hunger.

Policaptil Gel Retard ^® – action

The formula of the LibraMed medical device is based on the patented complex of polysaccharide macromolecules Policaptil Gel ^Retard® . The production technology used allows the combination of special polysaccharide fractions obtained from cellulose, fiber ( Opuntia Ficus-indica ), Riviera marshmallow ( Amorphophallus konjac K. Koch ), marshmallow ( Althaea officinalis ), in common ( Linum usitatissimum ), broad-leaved linden. ( Tilia platyphyllos ) and chicory ( Cichorium intybus ).

Policaptil Gel Retard ^® acts in the intestine, where, administered orally, it forms a very viscous gel. Facilitates the control of the postprandial glycemic peak by reducing the amount and speed of carbohydrate absorption ( the so-called "retard effect") Mechanism of action, Policaptil Gel ^Retard® reduces fat absorption , while supporting intestinal transit and regulating stool consistency.

LibraMed, combined with a balanced diet, adequate fluid intake and regular physical activity, due to its mechanism of action, is indicated for weight control in adults and children over 8 years of age.